Core Points - Dongbao Biological (300239) closed at 5.6 yuan on June 13, 2025, a 0.36% increase from the previous week's 5.58 yuan [1] - The company has a total market capitalization of 3.324 billion yuan, ranking 45th out of 50 in the bioproducts sector and 3972nd out of 5150 in the A-share market [1] Company Announcements - Dongbao Biological announced a cash dividend of 0.25 yuan per 10 shares (including tax) for the 2024 fiscal year, with the record date on June 16, 2025, and the ex-dividend date on June 17, 2025 [1][4] - The company will not issue new shares or use capital reserves for this dividend distribution, and the remaining undistributed profits will be carried forward to future distributions [1] - The adjusted cash dividend per 10 shares after the distribution will be approximately 0.245546 yuan (including tax) [1] Convertible Bond Adjustments - The conversion price for Dongbao Convertible Bonds (123214) will be adjusted from 6.65 yuan to 6.63 yuan per share, effective June 17, 2025 [2][4] - The company issued 455 million yuan worth of convertible bonds, with a total of 4.55 million bonds available for conversion [2] Share Buyback Adjustments - Following the 2024 dividend distribution, the maximum buyback price will be adjusted from 8.00 yuan to 7.98 yuan per share, with the expected buyback quantity adjusted to between 6,265,700 and 12,531,300 shares [3][4] - The buyback plan was approved on January 3, 2025, with a duration of 12 months [3]

Core Viewpoint - The company announces a temporary suspension of the conversion of its convertible bonds, effective from June 9, 2025, until the equity registration date for the 2024 annual equity distribution, to ensure the smooth implementation of the distribution [1] Group 1: Convertible Bonds Information - The convertible bonds (code: 123214; name: Dongbao Convertible Bonds) will be suspended for conversion during the specified period but will continue to trade normally [1] - The company will adjust the conversion price of the bonds in the event of stock dividends, capital increases, new share issuances, rights issues, or cash dividends, following a specific formula [1][2] - The adjustment formulas for the conversion price are detailed, including variables for stock dividends, new share prices, and cash dividends [1] Group 2: Price Adjustment Procedures - The company will publish announcements regarding the adjustment of the conversion price on the Shenzhen Stock Exchange website or other designated media, including the adjustment date and method [2] - In cases of share buybacks, mergers, splits, or other events affecting share categories or quantities, the company will adjust the conversion price to protect the rights of bondholders [2]